6446 1263

Cited 0 times in

줄기세포의 개요

DC Field Value Language
dc.contributor.author김동욱-
dc.contributor.author허용준-
dc.date.accessioned2018-10-12T05:36:49Z-
dc.date.available2018-10-12T05:36:49Z-
dc.date.issued2011-
dc.identifier.issn1738-1428-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/163566-
dc.description.abstractWe are now in the middle of stem cell war. Each country is trying to invest a large amount of funds into stem cell research. This is due to a potentiality of stem cells. Stem cells are capable of proliferating in an undifferentiated manner and are able to differentiate into a desired cell lineage under certain conditions. These abilities make stem cells an appealing source for cell replacement therapies (regenerative medicine), the study of developmental biology and drug/toxin screening. In addition to embryonic and adult stem cells, induced pluripotent stem (iPS) cells has been recently generated through reprogramming from adult tissue cells such as fibroblasts. This technique has opened up new avenues to generate patient- and disease-specific pluripotent stem cells. Human iPS cells may be useful for gaining valuable insight into the pathophysiology of disease, as well as for discovering for new prognostic biomarkers and drug screening. Moreover, the iPS cell technology may play a major role in immune-matched clinical application in the future. In this chapter, we introduce general characteristics of various stem cells, clinical application of stem cells and future perspectives-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageKorean-
dc.publisherKorean Neurological Association-
dc.relation.isPartOfJournal of the Korean Neurological Association-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title줄기세포의 개요-
dc.title.alternativeStem cells: general information and perspectives-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Physiology-
dc.contributor.googleauthor허용준-
dc.contributor.googleauthor김동욱-
dc.identifier.doi10.5124/jkma.2011.54.5.450-
dc.contributor.localIdA00406-
dc.contributor.localIdA04360-
dc.relation.journalcodeJ01835-
dc.subject.keywordStem cells-
dc.subject.keywordEmbryonic stem cells-
dc.subject.keywordAdult stem cells-
dc.subject.keywordInduced pluripotent stem cells-
dc.subject.keywordRegenerative medicine-
dc.contributor.alternativeNameKim, Dong Wook-
dc.contributor.alternativeNameHuh, Yong Jun-
dc.contributor.affiliatedAuthorKim, Dong Wook-
dc.contributor.affiliatedAuthorHuh, Yong Jun-
dc.citation.volume54-
dc.citation.number5-
dc.citation.startPage450-
dc.citation.endPage453-
dc.identifier.bibliographicCitationJournal of the Korean Neurological Association, Vol.54(5) : 450-453, 2011-
dc.identifier.rimsid58832-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Physiology (생리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.